(Q36794861)

16 August 2017

1 reference

title

Progress in vaccine development against Helicobacter pylori (English)

1 reference

16 August 2017

1 reference

1

Ann-Mari Svennerholm

1 reference

16 August 2017

Anna Lundgren

2

1 reference

16 August 2017

publication date

18 April 2007

1 reference

FEMS Immunology and Medical Microbiology

16 August 2017

published in

1 reference

16 August 2017

volume

50

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

146-156

1 reference

Helicobacter pylori vaccine development: facing the challenge

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Oral vaccination against Helicobacter pylori infection is not effective in mice with Fas ligand deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Immune subversion by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

HpaA is essential for Helicobacter pylori colonization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Characterization of the outer membrane protein profile from disease-related Helicobacter pylori isolates by subcellular fractionation and nano-LC FT-ICR MS analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Inflammation, immunity, vaccines for Helicobacter infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori VacA, a paradigm for toxin multifunctionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Inflammation, immunity and vaccines for Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Challenge model for Helicobacter pylori infection in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3beta) after exposure to Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Pathogenesis of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Vaccination against Helicobacter pylori in non-human primate models and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Human gastric B cell responses can be induced by intestinal immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Prospects for a mucosally-administered vaccine against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2007.00237.X

10.1111/J.1574-695X.2007.00237.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference